期 |
栏目 |
标题 |
文件 |
卷 2, 编号 2 (2000) |
Articles |
Problema osteoporoza i vozmozhnosti primeneniya miakal'tsika v onkologii |
|
卷 3, 编号 3 (2001) |
Articles |
Novye vozmozhnosti endokrinnoy terapii raka molochnoy zhelezy |
|
卷 3, 编号 3 (2001) |
Articles |
Perspektivy khimioterapii raka molochnoy zhelezy: vozmozhnosti gemzara po materialam ASCO 2001 g |
|
卷 6, 编号 1 (2004) |
Articles |
Fibrozno - kistoznaya bolezn' |
|
卷 6, 编号 2 (2004) |
Articles |
Novye aktsenty v endokrinnoy terapii raka molochnoy zhelezy |
|
卷 7, 编号 2 (2005) |
Articles |
Aromazin (ekzemestan) v neoad\"yuvantnoy i ad\"yuvantnoy gormonoterapii raka molochnoy zhelezy |
|
卷 11, 编号 1 (2009) |
Articles |
Effektivnost' Taksoterav neoad\"yuvantnoy i ad\"yuvantnoy khimioterapii raka molochnoy zhelezy (Po materialam mezhdunarodnykh issledovaniy) |
|
卷 11, 编号 2 (2009) |
Articles |
Rol' Taksotera v lechenii metastaticheskogo raka molochnoy zhelezy |
|
卷 12, 编号 1 (2010) |
Articles |
Mesto fulvestranta v endokrinoterapiimetastaticheskogo raka molochnoy zhelezy |
|
卷 13, 编号 3 (2011) |
Articles |
Osteopontin, CD55:prognosticheskie faktory riskapri rake molochnoy zhelezy |
|
卷 14, 编号 1 (2012) |
Articles |
Evolyutsiya ad\"yuvantnoy lekarstvennoyterapii «rannego» raka molochnoyzhelezy (mnogotsentrovoeissledovanie) |
|
卷 14, 编号 4 (2012) |
Articles |
Everolimus: novye perspektivy terapii gormonopozitivnogo raka molochnoy zhelezy |
|